PITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models ...

Predictive Oncology Inc. has announced the successful development of 3D organoid models specifically for Labcorp, which include unique human and rat liver toxicity models. These models are designed to ...

Scientists at EPFL have created a scalable 3D organoid model that captures key features of early limb development, revealing how a specialized signaling center shapes both cell identity and tissue ...

The 3D human breast organoid model represents state-of-the-art technology that "floats" patient-derived or stem cell-derived human breast tissue in a gel-like substance known as the matrix. The model ...

The 3D Ready ™ Organoid Expansion Service offers researchers a huge quantity of high-quality, low-variability organoids in an assay-ready configuration. Molecular Devices recognizes the difficulties ...

In the realm of in vitro three-dimensional (3D) culture technologies, particularly organoids, recent advancements have brought about significant changes in the creation of more physiologically ...

Organoid screening has emerged as one of the most significant methodological advances in preclinical drug discovery, offering three-dimensional, self-organizing cellular architectures that more ...

Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons, which leads to nigrostriatal impairment. Although induced pluripotent stem cell (iPSC ...

The 3D human breast organoid model represents state-of-the-art technology that “floats” patient-derived or stem cell-derived human breast tissue in a gel-like substance known as the matrix. The model ...